Maiden Stock Price, News & Analysis (NASDAQ:MHLD)

Maiden trades on the NASDAQ under the ticker symbol "MHLD."

Maiden Holdings, Ltd. (NASDAQ:MHLD) posted its quarterly earnings results on Monday, August, 12th. The insurance provider reported ($0.27) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.14 by $0.41. The insurance provider had revenue of $165.86 million for the quarter. Maiden had a negative return on equity of 308.89% and a negative net margin of 42.41%. View Maiden's Earnings History.

Maiden is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Maiden.

1 brokers have issued 1-year price targets for Maiden's stock. Their predictions range from $1.00 to $1.00. On average, they expect Maiden's stock price to reach $1.00 in the next twelve months. This suggests a possible upside of 55.0% from the stock's current price. View Analyst Price Targets for Maiden.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maiden in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Maiden.

Media stories about MHLD stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Maiden earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the insurance provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Maiden.

Maiden saw a decrease in short interest during the month of September. As of September 15th, there was short interest totalling 939,800 shares, a decrease of 7.9% from the August 15th total of 1,020,000 shares. Based on an average daily trading volume, of 401,700 shares, the short-interest ratio is presently 2.3 days. Currently, 1.7% of the shares of the company are short sold. View Maiden's Current Options Chain.

Some companies that are related to Maiden include Federated National (FNHC), Kingstone Companies (KINS), Blue Capital Reinsurance (BCRH), Kingsway Financial Services (KFS), ICC (ICCH), Conifer (CNFR), Unico American (UNAM), 1347 Property Insurance (PIH), Oxbridge Re (OXBR), Atlas Financial (AFH), Baldwin & Lyons Inc Class B (BWINB) and Till Capital (TIL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Maiden investors own include AmTrust Financial Services (AFSI), Ford Motor (F), Medical Properties Trust (MPW), New Residential Investment (NRZ), Catalyst Pharmaceuticals (CPRX), Centurylink (CTL), General Electric (GE), Teekay Lng Partners (TGP), Oncolytics Biotech (ONCYF) and Advanced Micro Devices (AMD).

Shares of MHLD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MHLD stock can currently be purchased for approximately $0.65.

Maiden has a market capitalization of $53.56 million and generates $2.16 billion in revenue each year. Maiden employs 74 workers across the globe.View Additional Information About Maiden.

The official website for Maiden is http://www.maiden.bm/.

Maiden's mailing address is 94 Pitts Bay Road, Pembroke D0, HM 08. The insurance provider can be reached via phone at 441-298-4900 or via email at [email protected]